These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7094507)

  • 21. [Clinical significance of plasma levels of clomipramine and its desmethylated and hydroxylated metabolites].
    Noguchi T
    Yakubutsu Seishin Kodo; 1993 Aug; 13(4):239-49. PubMed ID: 8237141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Citalopram: an interaction study with clomipramine in a patient heterozygous for CYP2D6 genotype.
    Haffen E; Vandel P; Broly F; Vandel S; Sechter D; Bizouard P; Bechtel PR
    Pharmacopsychiatry; 1999 Nov; 32(6):232-4. PubMed ID: 10599932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma concentration of clomipramine and desmethylclomipramine and clinical response in depressed patients.
    Montgomery SA; McAuley R; Montgomery DB; Dawling S; Braithwaite RA
    Postgrad Med J; 1980; 56 Suppl 1():130-3. PubMed ID: 7393823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Controlled comparison of buspirone and clomipramine in obsessive-compulsive disorder.
    Pato MT; Pigott TA; Hill JL; Grover GN; Bernstein S; Murphy DL
    Am J Psychiatry; 1991 Jan; 148(1):127-9. PubMed ID: 1984696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The biotransformation of clomipramine in vitro, identification of the cytochrome P450s responsible for the separate metabolic pathways.
    Nielsen KK; Flinois JP; Beaune P; Brøsen K
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1659-64. PubMed ID: 8667235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between the plasma concentration of clomipramine and desmethylclomipramine in depressive patients and the clinical response.
    Vandel B; Vandel S; Jounet JM; Allers G; Volmat R
    Eur J Clin Pharmacol; 1982; 22(1):15-20. PubMed ID: 7094971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolactin in childhood obsessive-compulsive disorder: clinical correlates and response to clomipramine.
    Hanna GL; McCracken JT; Cantwell DP
    J Am Acad Child Adolesc Psychiatry; 1991 Mar; 30(2):173-8. PubMed ID: 2016218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitors of serotonin and noradrenaline uptake in human plasma after withdrawal of zimelidine and clomipramine treatment.
    Ross SB; Aberg-Wistedt A
    Psychopharmacology (Berl); 1983; 79(4):298-303. PubMed ID: 6222388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Plasma levels of desmethylclomipramine and clomipramine at steady-state in the morning. Correlative analysis and prediction of theoretical blood clomipramine].
    Champiat JC; Aymard N; des Lauriers A
    Encephale; 1983; 9(1):23-36. PubMed ID: 6872932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interindividual variations of desmethylation and hydroxylation of clomipramine in an Oriental psychiatric population.
    Shimoda K; Minowada T; Noguchi T; Takahashi S
    J Clin Psychopharmacol; 1993 Jun; 13(3):181-8. PubMed ID: 8354734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clomipramine treatment of obsessive compulsive symptomatology in schizophrenic patients.
    Zohar J; Kaplan Z; Benjamin J
    J Clin Psychiatry; 1993 Oct; 54(10):385-8. PubMed ID: 7903293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antidepressant drugs in the treatment of obsessive-compulsive disorders.
    Stern R
    J Behav Ther Exp Psychiatry; 1983 Mar; 14(1):19-23. PubMed ID: 6863547
    [No Abstract]   [Full Text] [Related]  

  • 33. Simultaneous plasma level analysis of clomipramine, N-desmethylclomipramine, and fluvoxamine by reversed-phase liquid chromatography.
    Palego L; Marazziti D; Biondi L; Giannaccini G; Sarno N; Armani A; Lucacchini A; Cassano GB; Dell'Osso L
    Ther Drug Monit; 2000 Apr; 22(2):190-4. PubMed ID: 10774632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.
    Freeman CP; Trimble MR; Deakin JF; Stokes TM; Ashford JJ
    J Clin Psychiatry; 1994 Jul; 55(7):301-5. PubMed ID: 8071291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Obsessive-compulsive disorder: a double-blind, placebo-controlled trial of clomipramine in 27 patients.
    Jenike MA; Baer L; Summergrad P; Weilburg JB; Holland A; Seymour R
    Am J Psychiatry; 1989 Oct; 146(10):1328-30. PubMed ID: 2675643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are gender differences in antiobsessional response related to different clomipramine metabolism?
    Mundo E; Pirola R; Bellodi L; Smeraldi E; Bareggi SR
    J Clin Psychopharmacol; 2002 Jun; 22(3):341-2. PubMed ID: 12006911
    [No Abstract]   [Full Text] [Related]  

  • 37. [A control study of clomipramine and amitriptyline for treating obsessive-compulsive disorder].
    Zhao JP
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Apr; 24(2):68-70, 123. PubMed ID: 1860383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clomipramine for obsessive-compulsive disorder.
    Feinberg M
    Am Fam Physician; 1991 May; 43(5):1735-8. PubMed ID: 2021107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Response of obsessive-compulsive disorder and trichotillomania to serotonin reuptake blockers.
    Graae F; Gitow A; Piacentini J; Jaffer M; Liebowitz M
    Am J Psychiatry; 1992 Jan; 149(1):149-50. PubMed ID: 1728180
    [No Abstract]   [Full Text] [Related]  

  • 40. Clomipramine: an antiobsessional tricyclic antidepressant.
    Peters MD; Davis SK; Austin LS
    Clin Pharm; 1990 Mar; 9(3):165-78. PubMed ID: 2180623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.